Free Trial

Zynex (ZYXI) Stock Price, News & Analysis

Zynex logo
$1.57 +0.01 (+0.38%)
As of 12:30 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Zynex Stock (NASDAQ:ZYXI)

Advanced

Key Stats

Today's Range
$1.54
$1.62
50-Day Range
$1.26
$2.58
52-Week Range
$1.23
$9.42
Volume
35,739 shs
Average Volume
244,846 shs
Market Capitalization
$47.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.90
Consensus Rating
Hold

Company Overview

Zynex Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
53rd Percentile Overall Score

ZYXI MarketRank™: 

Zynex scored higher than 53% of companies evaluated by MarketBeat, and ranked 673rd out of 958 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Zynex has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.

  • Upside Potential

    Zynex has a consensus price target of $4.90, representing about 213.1% upside from its current price of $1.57.

  • Amount of Analyst Coverage

    Zynex has only been the subject of 3 research reports in the past 90 days.

  • Read more about Zynex's stock forecast and price target.
  • Earnings Growth

    Earnings for Zynex are expected to grow by 135.00% in the coming year, from $0.20 to $0.47 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Zynex is -1.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Zynex is -1.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Zynex has a P/B Ratio of 1.40. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Zynex's valuation and earnings.
  • Percentage of Shares Shorted

    20.11% of the float of Zynex has been sold short.
  • Short Interest Ratio / Days to Cover

    Zynex has a short interest ratio ("days to cover") of 12.3, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Zynex has recently increased by 1.42%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Zynex does not currently pay a dividend.

  • Dividend Growth

    Zynex does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    20.11% of the float of Zynex has been sold short.
  • Short Interest Ratio / Days to Cover

    Zynex has a short interest ratio ("days to cover") of 12.3, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Zynex has recently increased by 1.42%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Zynex has a news sentiment score of 1.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.92 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Zynex this week, compared to 9 articles on an average week.
  • Search Interest

    Only 2 people have searched for ZYXI on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Zynex insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    49.28% of the stock of Zynex is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 29.68% of the stock of Zynex is held by institutions.

  • Read more about Zynex's insider trading history.
Receive ZYXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zynex and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ZYXI Stock News Headlines

Zynex announces new executive team
Warren Buffett Issues Cryptic Warning on U.S. Dollar
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.tc pixel
Zynex welcomes Steve Dyson as CEO, adds to leadership team
Zynex Q2 Revenue Drops 55%
See More Headlines

ZYXI Stock Analysis - Frequently Asked Questions

Zynex's stock was trading at $8.01 at the start of the year. Since then, ZYXI shares have decreased by 80.5% and is now trading at $1.5650.

Zynex Inc. (NASDAQ:ZYXI) announced its earnings results on Monday, April, 28th. The company reported ($0.33) EPS for the quarter, missing analysts' consensus estimates of ($0.24) by $0.09. The company earned $26.58 million during the quarter, compared to analyst estimates of $30.83 million. Zynex had a negative net margin of 19.79% and a negative trailing twelve-month return on equity of 78.54%.
Read the conference call transcript
.

Zynex's top institutional shareholders include Janney Montgomery Scott LLC (1.46%), Arrowstreet Capital Limited Partnership (0.82%), Geode Capital Management LLC (0.63%) and RBF Capital LLC (0.50%). Insiders that own company stock include Thomas Sandgaard, Joshua R Disbrow, Anna Lucsok and Daniel J Moorhead.
View institutional ownership trends
.

Shares of ZYXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Zynex investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH), AU Optronics (AUOTY) and Humana (HUM).

Company Calendar

Last Earnings
4/28/2025
Today
9/17/2025
Next Earnings (Estimated)
10/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:ZYXI
CIK
846475
Fax
N/A
Employees
770
Year Founded
N/A

Price Target and Rating

High Price Target
$8.00
Low Price Target
$3.00
Potential Upside/Downside
+209.3%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.94)
Trailing P/E Ratio
N/A
Forward P/E Ratio
7.92
P/E Growth
N/A
Net Income
$2.99 million
Net Margins
-19.79%
Pretax Margin
-15.83%
Return on Equity
-78.54%
Return on Assets
-16.70%

Debt

Debt-to-Equity Ratio
0.56
Current Ratio
0.62
Quick Ratio
0.45

Sales & Book Value

Annual Sales
$192.35 million
Price / Sales
0.25
Cash Flow
$0.26 per share
Price / Cash Flow
6.06
Book Value
$1.12 per share
Price / Book
1.41

Miscellaneous

Outstanding Shares
30,300,000
Free Float
15,367,000
Market Cap
$48.00 million
Optionable
Optionable
Beta
1.02

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:ZYXI) was last updated on 9/17/2025 by MarketBeat.com Staff
From Our Partners